CytomX Therapeutics
NASDAQ: CTMXSouth San Francisco, US · Founded 2010 · Delaware corporation · 3 known investors
Clinical-stage biotechnology company developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment.
Biotech
Founders & leadership
TS
Tim ShannonDirector
FW
Frederick W. GluckDirector
EV
Elaine V. JonesDirector
SM
Sean McCarthyExecutive Officer, Director
NE
Neil ExterDirector
HH
Hoyoung HuhDirector
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$30MraisedAug 2023 · 4 investors · BiotechnologyRule 506(b)
▶$30MraisedAug 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Chris OgdenExecutive Officer
- Marcia BelvinExecutive Officer
- James MeyersDirector
- Alan AshworthDirector
- Matthew YoungDirector
- Jeff LandauExecutive Officer
- Halley GilbertDirector
- Wayne ChuExecutive Officer
- Elaine JonesDirector
- Mani MohindruDirector
- Sean McCarthyExecutive Officer, Director
- Lloyd RowlandExecutive Officer
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$70MraisedJun 2015 · 33 investors · BiotechnologyRule 506(b)
▶$70MraisedJun 2015 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rachel HumphreyDirector
- Tim ShannonDirector
- Frederick W. GluckDirector
- Hoyoung HuhDirector
- Elaine V. JonesDirector
- Neil ExterDirector
- Sean McCarthyExecutive Officer, Director
- Offering amount
- $70M
- Amount sold
- $70M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
▶$16.5MraisedJan 2015 · 4 investors · BiotechnologyRule 506(b)
▶$16.5MraisedJan 2015 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tim ShannonDirector
- Frederick W. GluckDirector
- Elaine V. JonesDirector
- Sean McCarthyExecutive Officer, Director
- Neil ExterDirector
- Hoyoung HuhDirector
- Offering amount
- $30M
- Amount sold
- $16.5M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.